Stay updated on Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision update shows v3.3.2 replacing v3.3.1 with no visible changes to the study content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:41:37.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The Publications section text was slightly reworded and the revision version updated from v3.2.0 to v3.3.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:49:40.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The government funding lapse notice about potential data not being up to date and response delays has been removed from this page.
    Difference
    0.4%
    Check dated 2025-11-17T06:55:11.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The page appears to retain the same core content with minor formatting changes or layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T01:17:16.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    - Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.
    Difference
    2%
    Check dated 2025-10-05T09:50:09.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0; no substantive content changes detected.
    Difference
    0.1%
    Check dated 2025-09-28T03:09:33.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Relapsed Mediastinal Lymphoma Clinical Trial page.